Abstract | BACKGROUND: AIMS: METHODS: RESULTS: 80.1% of men under examination and 81.9% of the women had suffered from their first MI. Only 9% of all patients were already under lipid-lowering therapy before the MI. After the MI TC and LDL-C levels decreased significantly in a time-dependent manner. Around 50% of patients received lipid-lowering drug, or the recommendation of one, during their hospital stay. CONCLUSION: The range of TC values of the patients examined was comparable to those in the CARE and the 4S secondary prevention studies. It can therefore be assumed that the results of these studies are also applicable to Germany. Nevertheless, according to existing data, therapy with lipid-lowering drugs is currently unsatisfactory, even in secondary prevention.
|
Authors | A Bergmann, J Schulze, D Hübner, A Weizel, U Julius, J Kreuzer |
Journal | European journal of epidemiology
(Eur J Epidemiol)
Vol. 18
Issue 5
Pg. 407-11
( 2003)
ISSN: 0393-2990 [Print] Netherlands |
PMID | 12889686
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
- Cholesterol, HDL
- Cholesterol, LDL
- Hypolipidemic Agents
- Triglycerides
- Cholesterol
|
Topics |
- Aged
- Aged, 80 and over
- Cholesterol
(blood)
- Cholesterol, HDL
(blood, drug effects)
- Cholesterol, LDL
(blood, drug effects)
- Female
- Germany
- Humans
- Hypolipidemic Agents
(therapeutic use)
- Male
- Middle Aged
- Myocardial Infarction
(drug therapy, prevention & control)
- Random Allocation
- Sex Factors
- Time Factors
- Treatment Outcome
- Triglycerides
(blood)
|